| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| cdc prep guidelines cabotegravir | 1.25 | 0.4 | 1184 | 58 | 32 |
| cdc | 1.39 | 0.4 | 8566 | 44 | 3 |
| prep | 1.93 | 0.1 | 5196 | 14 | 4 |
| guidelines | 1.54 | 0.1 | 746 | 45 | 10 |
| cabotegravir | 0.66 | 0.9 | 6327 | 97 | 12 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| cdc prep guidelines cabotegravir | 1.94 | 0.6 | 4578 | 86 |
| cabotegravir la for prep | 1.56 | 0.9 | 4914 | 28 |
| cabotegravir for prep clinical trials | 0.94 | 0.8 | 8505 | 43 |
| is cabotegravir approved for prep | 1.34 | 0.7 | 1495 | 5 |
| cabotegravir prep fda approval | 1.22 | 0.8 | 997 | 60 |
| long acting cabotegravir prep | 1.42 | 0.2 | 1468 | 60 |
| cabotegravir package insert pdf | 1.85 | 0.2 | 4411 | 53 |
| cabotegravir route of administration | 0.94 | 0.4 | 1040 | 91 |
| cabotegravir mode of action | 1.5 | 0.6 | 4469 | 17 |
| cabotegravir long acting injectable | 1.6 | 0.9 | 1676 | 94 |
| cabotegravir medication for hiv | 0.84 | 0.4 | 5081 | 55 |
| cdc coronavirus positive guidelines | 1.55 | 0.6 | 7733 | 33 |
| cabotegravir oral lead in | 1.93 | 0.1 | 638 | 10 |
| cabotegravir and rilpivirine package insert | 0.5 | 1 | 9032 | 79 |
| cdc gov coronavirus guidelines | 1.36 | 0.8 | 8345 | 71 |
